Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 773 | 1,989 | 2,377 | 867 | 753 |
| Operating Income | -773 | -1,989 | -2,377 | -867 | -753 |
| Other Income | 27 | 20 | 17 | 4 | 4 |
| Pre-tax Income | -746 | -1,970 | -2,361 | -863 | -750 |
| Net Income Continuous | -746 | -1,970 | -2,361 | -863 | -750 |
| Net Income | $-746 | $-1,970 | $-2,361 | $-863 | $-750 |
| EPS Basic Total Ops | -0.06 | -0.15 | -0.17 | -0.07 | -0.06 |
| EPS Basic Continuous Ops | -0.06 | -0.15 | -0.18 | -0.07 | -0.06 |
| EPS Diluted Total Ops | -0.06 | -0.15 | -0.17 | -0.07 | -0.06 |
| EPS Diluted Continuous Ops | -0.06 | -0.15 | -0.18 | -0.07 | -0.06 |
| EBITDA(a) | $-772 | $-1,988 | $-2,376 | $-866 | $-753 |